Sorbie Bornholm LP
  • The Sorbie-Strategy
  • Our Team
  • News
  • Locations
    • Australia
    • United Kingdom
    • United States
  • Contact Us
Select Page

Sorbie Bornholm Announces New Investment of $3.8m in Bee Vectoring Technologies International Inc.

by Editorial Staff | Jul 13, 2022 | News Release

London, UK – July 13, 2022 – Sorbie Bornholm LP, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Bee Vectoring Technologies International Inc. (“BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE). The gross amount of the investment is $3.8...

Sorbie Bornholm Announces New Investment of $5.125m in Tocvan Ventures Corp.

by Editorial Staff | Jul 1, 2022 | News Release

London, UK – June 30, 2022 – Sorbie Bornholm LP, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Tocvan Ventures Corp. (the “Company”) (CSE: TOC; OTCQB: TCVNF; WKN: TV3/A2PE64). The gross amount of the investment is $5.125 million...

Sorbie Bornholm Announces New Investment of $2.568m in Sixth Wave Innovations Inc.

by Editorial Staff | Mar 24, 2022 | News Release

London, UK – March 24, 2022 – Sorbie Bornholm, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Sixth Wave Innovations, Inc., (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave” or the “Company”) a nanotechnology company with patented...

Kogi Iron Announces Share Placement and Share Purchase Plan

by Editorial Staff | Nov 21, 2019 | News Release

Sorbie works with Kogi Iron for up to $4.35m Investment Kogi Iron Limited (ASX: KFE) (“Kogi”, “Kogi Iron” or the “Company”) and its 100% owned Nigerian operating company, KCM Mining Limited (“KCM”) are pleased to announce the following capital raisings: share...

Neuren Pharmaceuticals bags A$11.5M to progress Rett syndrome trials

by Editorial Staff | Jun 29, 2017 | News Release

Placement anchored by A$10 million from UK fund Neuren Pharmaceuticals (ASX:NEU) has secured a funding of A$11.5 million via the placement of shares at $0.062 each, to enable the initiation of key activities for commencing a Phase 3 trial in Rett syndrome. Neuren is...

Recent Posts

  • Sorbie Bornholm Announces New Investment of $3.8m in Bee Vectoring Technologies International Inc.
  • Sorbie Bornholm Announces New Investment of $5.125m in Tocvan Ventures Corp.
  • Sorbie Bornholm Book Club – The Wolf of Wall Street
  • Sorbie Bornholm Announces New Investment of $2.568m in Sixth Wave Innovations Inc.
  • Introducing the Sorbie Bornholm Book Club!

Archives

  • July 2022
  • April 2022
  • March 2022
  • March 2021
  • February 2021
  • November 2019
  • May 2018
  • October 2017
  • June 2017
  • Follow
  • Follow
  • Follow
  • Follow

Sorbie-Strategy  Our Team  News  Contact Us

Terms of Use  Privacy Policy

Copyright © 2023 Sorbie Bornholm LP | All Rights Reserved